Kicking off #VEITH24 at the @WLGoreMedical pavilion. This is always a great opportunity to hear the latest data and connect with physicians from around the globe. Hope to see you here in NYC.
Jason Belzer retweeted
NYEVS is only 7 wks away, register at nyevs.org/
NYEVS is a multidisciplinary conference focused on the diagnosis and treatment of Peripheral Vascular Disease.
#endovascular #cardiology #peripheral #PAD #interventionalcardiology #aortic #cardiox #cardiotwitter
Seeing the team at @ChristHospital led by @JDCorlMD provide world class care and utilize this emerging technology is another reason I’m #ProudtobeAbbott
1st in the region and #9 in the world 🌎 to deploy the Abbott ESPRIT BTK Resorbable Scaffold today. #IVUS pre and post (see image). @TCHheart @ChristHospital #CLI #PAD @AbbottNews #SnareJordan
Having two leaders in imaging sharing their experience with Ultreon 2 is a great opportunity to learn from some of the best. @ziadalinyc @DrNataliaP #ProudtobeAbbott
#EuroPCR offering more hands-on training. @DrNataliaP and @ziadalinyc sharing their wisdom on #OCTimaging guided PCIs and showing how with the AI driven #Ultreon.
We followed a great morning with a wonderful afternoon watching the first Esprit BTK commercial case at Columbia performed by @sahilparikhmd @AbbottCardio #ProudtobeAbbott
Spending the morning with @derubertisMD observing the first commercial Esprit BTK case at Cornell is a great way to start the day. We are excited about what this therapy is bringing to patients. @AbbottCardio #ProudtobeAbbott
Seeing novel technology delivered to patients by a world class medical team is truly one of the most enjoyable parts of this job! #ProudtobeAbbott @PK_MountSinai
The first patient has been successfully treated with our Esprit BTK Everolimus Eluting Resorbable Scaffold System, pioneering a new standard of care in BTK treatment.
Thanks @PK_MountSinai and team for your commitment to your patients.
Safety Info: bit.ly/3WAocNk
Jason Belzer retweeted
Diamondback 360 Precision™ is here!
With an enhanced drive shaft and GlideAssist™ mode, there's no need to ask, our new orbital #Atherectomy system is a 🎶smooth operator🎶.
Check it out, #CardioTwitter: bit.ly/3spNQIa
Safety Info: bit.ly/47W9HFU
Jason Belzer retweeted
Thrilled to join @AbbottCardio as the Chief Medical Officer for Vascular. The space is more exciting than ever, and Abbott is on the leading edge of innovation.
Thankful for 15yrs at @ProvHealth with extraordinary colleagues. So much good to come!
#AbbottProud #CardioTwitter
Jason Belzer retweeted
📣Big News! Our first-of-its-kind #TriClip G4 TEER system that’s specifically designed for treatment of tricuspid regurgitation has received FDA approval!
Read the press release: abbo.tt/TriClip_PR
Safety Info: abbo.tt/TriClip_ISI
#TricuspidRegurgitation #TEER
Jason Belzer retweeted
Don’t miss it! Abbott Endomasters in Miami! Join @PK_MountSinai @SriniTummala @mcbunte @artleemd , Alfio Carroccio for PAD/CLTI talks, live case, pedal loop, DVA and some sun and surf on the side! @SIRspecialists @ACCinTouch @VascularSVS @EndovascularNy web.cvent.com/event/cde6b589…
Jason Belzer retweeted
How can AI-enabled Ultreon Software help teach how to use #OCTimaging? In this video, Dr. Croce shares his thoughts based on his experience with the software.
Learn more: Ultreon.com
#imagefirst #cardiotwitter
Important Safety Info: bit.ly/ISI_info
Jason Belzer retweeted
Find us at #AFS2024 in Booth 403 to learn how you can achieve immediate and durable #Hemostasis with our #Perclose Prostyle SMCR System.¹
Discover the benefits of adding this device to your EP workflows: bit.ly/415VODd
Safety Info: bit.ly/47SRjhX
Ultreon 2.0 is now available throughout the US. Image guided PCI is an important part of the treatment algorithm and OCT powered by Ultreon 2.0 brings this technology to the forefront. Another reason I’m #ProudtobeAbbott
Intuitive.💡 Fast.💨 Efficient.✅
The next generation of intravascular imaging software is here. Experience the first #OCTimaging platform powered by AI with Ultreon 2.0 Software – now available in the US: Ultreon.com
Safety Info: bit.ly/U2-ISI
#ImageFirst
Earlier today Dr Bertolet and the team at North Mississippi Medical Center used the Surveil DCB for the first time commercially here in the US. Partnering with physicians to bring forward technology to advance patient care is a big reason I’m #ProudtobeAbbott
Bringing new technology to patients and our partners is always an exciting time for us. Dr. Kini and the team at Mt. Sinai were the first in the US to use the new long length Xience Skypoint 48 post approval. Congratulations to the team!
Jason Belzer retweeted
At #TCT2023, @sahilparikhmd, @RamonVarcoeMD, @EricSecemskyMD, @Kandzari, and Dominick Angiolillo discuss the efficacy and safety of Esprit BTK for the treatment of CLTI.
tctmd.com/news/life-btk-bior…
Jason Belzer retweeted
In the U.S. alone, peripheral artery disease affects over 8 million people. That’s why we’re working on groundbreaking treatment options to help treat blocked arteries.
Check out the latest data from LIFE-BTK: abbo.tt/45KrVsO
A full house to hear @samitshahmd talk about the diagnosis and treatment of microvascular disease. #TCT2023 is a fantastic meeting here in San Francisco. #proudtobeabbott
Happy Friday! I’m starting my evening at the first ever Thrombus Masters course here in Denver. We are honored to have a wonderful panel leading lively discussions about thrombus management. A big thank you to Drs. @PK_MountSinai Emily Malgor, Ian Del Conde and Mahmood Razavi.



























